Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific: Paul Parker

Paul Parker will join Thermo Fisher Scientific as VP of strategy and corporate development, starting April 15. He will join the company from Goldman Sachs, where he was co-chairman of global mergers & acquisitions and a member of the firm's partnership committee. Previously, he held operating and client relationship roles at Goldman Sachs, Barclays, Lehman Brothers, and JP Morgan. Parker has degrees from Harvard Business School and from the University of North Carolina at Chapel Hill.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.